Achromobacter Infections and Treatment Options
Achromobacter is a genus of nonfermenting Gram-negative bacteria under order
Burkholderiales. Although primarily isolated from respiratory tract of people with cystic …
Burkholderiales. Although primarily isolated from respiratory tract of people with cystic …
Achromobacter Respiratory Infections
CE Swenson, RT Sadikot - Annals of the American Thoracic Society, 2015 - atsjournals.org
Achromobacteria are ubiquitous environmental organisms that may also become
opportunistic pathogens in certain conditions, such as cystic fibrosis, hematologic and solid …
opportunistic pathogens in certain conditions, such as cystic fibrosis, hematologic and solid …
[HTML][HTML] Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series
EP Barragán, JS Pérez, L Corbella… - Revista Española de …, 2018 - ncbi.nlm.nih.gov
Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year
case series - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
case series - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Achromobacter spp. healthcare associated infections in the French West Indies: a longitudinal study from 2006 to 2016
K Marion-Sanchez, K Pailla, C Olive… - BMC Infectious …, 2019 - Springer
Abstract Background Bacteria of the Achromobacter genus, more particularly xylosoxidans
species, are responsible for various healthcare associated infections (HAI) which are …
species, are responsible for various healthcare associated infections (HAI) which are …
A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species
T Spilker, P Vandamme, JJ LiPuma - Journal of clinical …, 2012 - Am Soc Microbiol
The genus Achromobacter currently is comprised of seven species, including
Achromobacter xylosoxidans, an opportunistic and nosocomial pathogen that displays …
Achromobacter xylosoxidans, an opportunistic and nosocomial pathogen that displays …
Achromobacter xylosoxidans Bacteremia: Report of Four Cases and Review of the Literature
JM Duggan, SJ Goldstein… - Clinical infectious …, 1996 - academic.oup.com
Seventy-seven cases of bacteremia due to Achromobacter xylosoxidans were reviewed, and
susceptibility studies were performed on 11 clinical isolates of A. xylosoxidans. Nosocomial …
susceptibility studies were performed on 11 clinical isolates of A. xylosoxidans. Nosocomial …
Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989–2003)
G Aisenberg, KV Rolston, A Safdar - Cancer, 2004 - Wiley Online Library
BACKGROUND Achromobacter and Alcaligenes are emerging infectious gram‐negative
bacterial species that can affect immunosuppressed patients. The authors sought to …
bacterial species that can affect immunosuppressed patients. The authors sought to …
Ribosomal DNA-Directed PCR for Identification of Achromobacter (Alcaligenes) xylosoxidans Recovered from Sputum Samples from Cystic Fibrosis Patients
L Liu, T Coenye, JL Burns, PW Whitby… - Journal of clinical …, 2002 - Am Soc Microbiol
The opportunistic human pathogen Achromobacter (Alcaligenes) xylosoxidans has been
recovered with increasing frequency from respiratory tract culture of persons with cystic …
recovered with increasing frequency from respiratory tract culture of persons with cystic …
Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies
Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and nonmelioid Burkholderia
species, namely, Burkholderia cepacia complex, collectively are a group of troublesome …
species, namely, Burkholderia cepacia complex, collectively are a group of troublesome …
Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans
Achromobacter xylosoxidans is an opportunistic pathogen known to be resistant to a wide
range of antibiotics; however, the knowledge about the drug resistance mechanisms is …
range of antibiotics; however, the knowledge about the drug resistance mechanisms is …